Irbesartan In Hypertensive Diabetic Patients.

Trial Profile

Irbesartan In Hypertensive Diabetic Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2011

At a glance

  • Drugs Irbesartan; Irbesartan/hydrochlorothiazide
  • Indications Diabetic nephropathies; Hypertension; Proteinuria
  • Focus Therapeutic Use
  • Acronyms I-PREVENT
  • Sponsors Sanofi
  • Most Recent Events

    • 01 Apr 2011 Actual patient numbers of 797 added
    • 03 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Oct 2008 Planned end date changed from 1 Sep 2008 to 1 Oct 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top